WeChat Mini Program
Old Version Features

Phase II Study of Dose-Dense Docetaxel (T) and Epirubicin (E) As Neoadjuvant Treatment for Locally Advanced Breast Cancer (LABC). an ONCOPAZ Cooperative Group Study

A Lorenzo,C Madronal, JJ Sanz, M Centelles,MR Lopez,A Casas, VG Peez,CG de la Puente,MJG Lopez,P Borrega

Journal of Clinical Oncology（2005）

Cited 24|Views27
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined